Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC [0.03%]
正本清源：HCV相关肝细胞癌患者的治疗获益及结局分析
María Fernanda Guerra-Veloz,Sital Shah,Beatrice Emmanouil et al.
María Fernanda Guerra-Veloz et al.
The effectiveness of direct acting antiviral (DAA) therapy in patients with active hepatocellular carcinoma (HCC) is poorly defined. NHS England approved DAA therapy for all viraemic patients, including those with HCC. The aim of this retro...
Real-World Impact of a Simplified 'Test and Treat' Strategy for In-Hospital HCV Micro-Elimination [0.03%]
简化的"检测和治疗"策略实现院内HCV微消除的现实世界影响分析
Chunfang You,Yuting Diao,Juan Tang et al.
Chunfang You et al.
Hepatitis C virus (HCV) micro-elimination faces challenges from fragmented care pathways, particularly in high-prevalence regions with complex genotypes and socioeconomic barriers. This study evaluated a simplified 'Test and Treat' (TNT) st...
A Community-Engaged Approach to Identifying and Addressing Viral Hepatitis Determinants in Michigan Asian American Communities [0.03%]
一种在密歇根亚洲美国社区中确定和解决病毒性肝炎决定因素的参与式社区方法
Parnnate Wongsirisakul,Neehar D Parikh,Jonathan Troost et al.
Parnnate Wongsirisakul et al.
Approximately 75% of people infected with the hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States (U.S.) have yet to be tested, thus leading to the risk of liver disease progression that can be prevented by early diagno...
Uptake of the Birth Dose HBV Vaccine and Associated Factors Among Children in Sub-Saharan Africa: An Analysis Using Recent Demographic and Health Survey Data [0.03%]
撒哈拉以南非洲儿童乙肝疫苗首剂接种率及影响因素：基于近期人口与健康调查数据的分析
Alemayehu Kasu Gebrehana,Angwach Abrham Asnake,Beminate Lemma Seifu et al.
Alemayehu Kasu Gebrehana et al.
The hepatitis B virus birth dose vaccine (HepB-BD) is administered within the first 24 h after birth. When given during this period, along with at least two additional doses, it effectively prevents perinatal HBV infection and induces immun...
Progress Towards Elimination: Hepatitis B and C Among Children and Young Adults in Rural Mongolia [0.03%]
蒙古农村地区儿童和青年人群的乙肝和丙肝发病情况及消除进展
Esugen D Dashdorj,Khishigtogtokh Sereenendorj,Byambasuren Ochirsum et al.
Esugen D Dashdorj et al.
Mongolia is a global hotspot for viral hepatitis, with estimated rates of chronic hepatitis B (HBV) of 11% and hepatitis C (HCV) of 8.5% among adults. Data on infections among children and young adults and the impact of vaccination against ...
Viral Hepatitis B, C and Delta in Greenland: A National Cross-Sectional Study [0.03%]
格陵兰病毒性乙型、丙型和丁型肝炎的流行现状全国横断面研究
Carina Nørskov Naustdal,Gerda Elisabeth Villadsen,Karsten Fleischer Rex et al.
Carina Nørskov Naustdal et al.
Viral hepatitis B infection is considered endemic in Greenland as in other Arctic areas. However, updated data are warranted after the implementation of screening, vaccination and treatment programmes during the past decades. We aimed to in...
Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial [0.03%]
富马酸tenofovir alafenamide对血清HBeAg阴性及ALT正常的慢性乙肝患者病毒学抑制作用：一项为期48周的随机对照试验
Qiumin Luo,Wenxiong Xu,Yeqiong Zhang et al.
Qiumin Luo et al.
The optimal strategy for chronic hepatitis B virus (HBV) infected patients with negative hepatitis B e-antigen (HBeAg) and normal alanine aminotransferase (ALT) remains uncertain. This study aimed to evaluate the safety and efficacy of teno...
Randomized Controlled Trial
Journal of viral hepatitis. 2026 Mar;33(3):e70141. DOI:10.1111/jvh.70141 2026
HCV Cure: To Bridge the Gaps in the Care Continuum [0.03%]
打通丙肝治疗全程关卡路远amaha侍從巫師青年們仍在學習，尚未能獨當一面。重任只好交給三名元老級角色：金毛狮王、青翼蝠王和白眉鹰王。金毛狮王谢逊武功盖世，性格暴烈，曾是明教四大护教法王之首；青翼蝠王 Sewaldehyde for Chemical Warfare Agents
Stanislas Pol,Denis Ouzan,Laurent Cattan
Stanislas Pol
Synchronous Telemedicine Versus In-Person Care in Hepatitis C Treatment: A Systematic Review and Meta-Analysis [0.03%]
同步远程医疗服务与面对面护理在丙型肝炎治疗中的比较：系统评价和 meta 分析
Igor Boechat Silveira,Gustavo Procópio Silva,Arthur Victor de Holanda Sampaio et al.
Igor Boechat Silveira et al.
Inequitable access to HCV treatment persists, particularly for rural and marginalised populations. Synchronous telemedicine (TM) could mitigate access barriers, but its comparative effectiveness versus in-person care is uncertain. We perfor...
Meta-Analysis
Journal of viral hepatitis. 2026 Mar;33(3):e70144. DOI:10.1111/jvh.70144 2026
Impact of Direct-Acting Antivirals Availability on Hepatitis C-Related Hospitalisations After Eight Years of the Strategic Plan for Tackling Hepatitis C Implementation in Spain [0.03%]
西班牙实施八年《应对丙型肝炎战略计划》后直接抗病毒药物的可获得性对丙型肝炎相关住院的影响
Macarena Garrido-Estepa
Macarena Garrido-Estepa
The Strategic Plan for Tackling Hepatitis C launched by the Ministry of Health in 2015 led to an important nationwide decrease in chronic hepatitis C-related hospitalisation rates by 2018 (25.8% of decrease compared to 2014 rates). This wor...